Top ten biotechnologies for improving health in developing countries
Abdallah S. Daar,Halla Thorsteinsdóttir,Douglas K. Martin,Alyna C. Smith,Shauna Nast,Peter Singer,Peter Singer +6 more
Reads0
Chats0
TLDR
An international group of eminent scientists with expertise in global health issues was asked to identify the top ten biotechnologies for improving health in developing countries, and the results offer concrete guidance to those in a position to influence the direction of research and development.Abstract:
Most research into genomics and other related biotechnologies is concerned with the priorities of industrialized nations, and yet a limited number of projects have shown that these technologies could help improve health in developing countries. To encourage the successful application of biotechnology to global health, we carried out a study in which we asked an international group of eminent scientists with expertise in global health issues to identify the top ten biotechnologies for improving health in developing countries. The results offer concrete guidance to those in a position to influence the direction of research and development, and challenge common assumptions about the relevance and affordability of biotechnology for developing countries.read more
Citations
More filters
Journal ArticleDOI
Patterned Paper as a Platform for Inexpensive, Low‐Volume, Portable Bioassays
TL;DR: This communication describes a simple method for patterning paper to create well-defined, millimeter-sized channels, comprising hydrophilic paper bounded by hydrophobic polymer, that will become the basis for low-cost, portable, and technically simple multiplexed bioassays.
Journal ArticleDOI
Diagnostics for the Developing World: Microfluidic Paper-Based Analytical Devices
TL;DR: Microfluidic paper-based analytical devices are a new class of point-of-care diagnostic devices that are inexpensive, easy to use, and designed specifically for use in developing countries.
Journal ArticleDOI
Simple telemedicine for developing regions: camera phones and paper-based microfluidic devices for real-time, off-site diagnosis.
Andres W. Martinez,Scott T. Phillips,Emanuel Carrilho,Samuel W. Thomas,Hayat Sindi,George M. Whitesides +5 more
TL;DR: A prototype system for quantifying bioassays and for exchanging the results of the assays digitally with physicians located off-site offers new opportunities for inexpensive monitoring of health, especially in situations that require physicians to travel to patients to obtain diagnostic information that might be obtained more effectively by less valuable personnel.
Journal ArticleDOI
Three-dimensional microfluidic devices fabricated in layered paper and tape.
TL;DR: A method for fabricating 3D microfluidic devices by stacking layers of patterned paper and double-sided adhesive tape to carry out a range of new analytical protocols simply and inexpensively without external pumps is described.
Journal ArticleDOI
Lab-on-a-chip devices for global health: Past studies and future opportunities
TL;DR: This review identifies diseases that are most in need of new health technologies, special design criteria for LOC devices to be deployed in a variety of resource-poor settings, and review past research into LOC devices for global health.
References
More filters
Book
Gazing into the oracle : the Delphi method and its application to social policy and public health
Erio Ziglio,Michael Adler +1 more
TL;DR: Theoretical, Methodological and Practical Issues Arising out of the Delphi Method, Armando Rotondi and David Gustafson.
Journal ArticleDOI
Inhibitors of the Nonmevalonate Pathway of Isoprenoid Biosynthesis as Antimalarial Drugs
Hassan Jomaa,Jochen Wiesner,Silke Sanderbrand,Boran Altincicek,Claus Weidemeyer,Martin Hintz,Ivana Türbachova,Matthias Eberl,Johannes Zeidler,Hartmut K. Lichtenthaler,Dominique Soldati,Ewald Beck +11 more
TL;DR: A mevalonate-independent pathway of isoprenoid biosynthesis present in Plasmodium falciparum was shown to represent an effective target for chemotherapy of malaria and the presence of two genes encoding the enzymes DOXP synthase and DOXP reductoisomerase suggests that isoprene biosynthesis in P. falcIParum depends on the DOXP pathway.
Journal ArticleDOI
Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development.
Michael R. Boyd,Kirk R. Gustafson,J B McMahon,Robert H. Shoemaker,Barry R. O'Keefe,Toshiyuki Mori,R J Gulakowski,L Wu,M I Rivera,C M Laurencot,M J Currens,J H Cardellina,Robert W. Buckheit,P L Nara,Lewis K. Pannell,R C Sowder,L E Henderson +16 more
TL;DR: The novel 11-kDa virucidal protein, named cyanovirin-N (CV-N), is isolated and sequenced from cultures of the cyanobacterium (blue-green alga) Nostoc ellipsosporum and is highly resistant to physicochemical denaturation, further enhancing its potential as an anti-HIV microbicide.
Journal ArticleDOI
Efficacy of RTS, S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial
Kalifa Bojang,Paul Milligan,Margaret Pinder,Laurence Vigneron,Ali Alloueche,Kent E. Kester,W. Ripley Ballou,David J. Conway,William H. H. Reece,Philip Gothard,Lawrence Yamuah,Martine Delchambre,Gerald Voss,Brian Greenwood,Adrian V. S. Hill,Keith P. W. J. McAdam,Nadia Tornieporth,Joe Cohen,Tom Doherty +18 more
TL;DR: RTS,S/AS02 is safe, immunogenic, and is the first pre-erythrocytic vaccine to show significant protection against natural P. falciparum infection in semi-immune adult men in The Gambia.